$ELV
Elevance Health, Inc. Stock $elv

$elv Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000119312513170158 Filed on April 24, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$17.58B	$15.42B
YoY Change	14.02%	3.5%
Cost Of Revenue	$65.00M	$0.00
YoY Change		-100.0%
Gross Profit	$17.51B	$15.42B
YoY Change	13.6%	320.46%
Gross Profit Margin	99.63%	100.0%
Selling, General & Admin	$2.329B	$2.166B
YoY Change	7.54%	4.3%
% of Gross Profit	13.3%	14.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.30M	$23.50M
YoY Change	7.66%	0.43%
% of Gross Profit	0.14%	0.15%
Operating Expenses	$2.329B	$2.166B
YoY Change	7.54%	4.3%
Operating Profit	$1.357B	$1.213B
YoY Change	11.93%	-10.2%
Interest Expense	$153.5M	$109.1M
YoY Change	40.7%	3.02%
% of Operating Profit	11.31%	9.0%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.283B	$1.310B
YoY Change	-2.08%	-8.22%
Income Tax	$410.2M	$453.3M
% Of Pretax Income	31.98%	34.61%
Net Earnings	$885.2M	$856.5M
YoY Change	3.35%	-7.57%
Net Earnings / Revenue	5.04%	5.56%
Basic Earnings Per Share	$2.92	$2.56
Diluted Earnings Per Share	$2.89	$2.53
COMMON SHARES
Basic Shares Outstanding	303.2M shares	335.0M shares
Diluted Shares Outstanding	305.9M shares	339.0M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.48B	$18.48B
YoY Change	5.43%
Cash & Equivalents	$1.660B	$2.279B
Short-Term Investments	$17.82B	$16.20B
Other Short-Term Assets	$1.891B	$1.921B
YoY Change	-1.54%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$28.66B	$27.54B
YoY Change	4.06%	2903.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.738B	$1.455B
YoY Change	19.49%	22.65%
Goodwill	$17.49B	$13.86B
YoY Change	26.2%
Intangibles	$9.056B	$7.878B
YoY Change	14.95%
Long-Term Investments	$21.17B	$18.76B
YoY Change	12.87%	2.46%
Other Assets	$483.3M	$445.7M
YoY Change	8.44%	-64.23%
Total Long-Term Assets	$30.75B	$24.95B
YoY Change	23.22%	-50.1%
TOTAL ASSETS
Total Short-Term Assets	$28.66B	$27.54B
Total Long-Term Assets	$30.75B	$24.95B
Total Assets	$59.41B	$52.50B
YoY Change	13.17%	3.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.937B	$2.810B
YoY Change	4.52%	5.36%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$350.0M	$100.0M
YoY Change	250.0%	0.0%
Long-Term Debt Due	$399.4M	$910.8M
YoY Change	-56.15%	153.7%
Total Short-Term Liabilities	$16.03B	$15.96B
YoY Change	0.47%	260.16%
LONG-TERM LIABILITIES
Long-Term Debt	$14.03B	$8.463B
YoY Change	65.79%	-0.93%
Other Long-Term Liabilities	$971.8M	$1.025B
YoY Change	-5.19%	-67.46%
Total Long-Term Liabilities	$15.00B	$9.488B
YoY Change	58.12%	-18.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.03B	$15.96B
Total Long-Term Liabilities	$15.00B	$9.488B
Total Liabilities	$35.09B	$28.97B
YoY Change	21.14%	7.53%
SHAREHOLDERS EQUITY
Retained Earnings	$13.28B	$11.92B
YoY Change	11.36%
Common Stock	$3.000M	$3.300M
YoY Change	-9.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.32B	$23.53B
YoY Change
Total Liabilities & Shareholders Equity	$59.41B	$52.50B
YoY Change	13.17%	3.1%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	$885.2M	$856.5M
YoY Change	3.35%	-7.57%
Depreciation, Depletion And Amortization	$25.30M	$23.50M
YoY Change	7.66%	0.43%
Cash From Operating Activities	$956.9M	$1.223B
YoY Change	-21.76%	9.7%
INVESTING ACTIVITIES
Capital Expenditures	$107.5M	$123.8M
YoY Change	-13.17%	21.49%
Acquisitions	$0.00	$1.200M
YoY Change	-100.0%
Other Investing Activities	$0.00	$600.0K
YoY Change	-100.0%	-95.52%
Cash From Investing Activities	-$1.196B	$20.10M
YoY Change	-6048.26%	-92.87%
FINANCING ACTIVITIES
Cash Dividend Paid	$113.4M	$95.80M
YoY Change	18.37%	3.23%
Common Stock Issuance & Retirement, Net	$340.2M	$679.8M
YoY Change	-49.96%	-8.33%
Debt Paid & Issued, Net	$556.9M	$350.8M
YoY Change	58.75%	-49.94%
Cash From Financing Activities	-$579.1M	-$1.167B
YoY Change	-50.38%	48.51%
NET CHANGE
Cash From Operating Activities	$956.9M	$1.223B
Cash From Investing Activities	-$1.196B	$20.10M
Cash From Financing Activities	-$579.1M	-$1.167B
Net Change In Cash	-$817.8M	$76.20M
YoY Change	-1173.23%	-87.53%
FREE CASH FLOW
Cash From Operating Activities	$956.9M	$1.223B
Capital Expenditures	$107.5M	$123.8M
Free Cash Flow	$849.4M	$1.099B
YoY Change	-22.73%	8.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	WellPoint, Inc.
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001156039
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	300362528	shares
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Trading Symbol TradingSymbol	WLP
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	17819100000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	483300000	USD
CY2013Q1	us-gaap	Assets Assets	59408600000	USD
CY2013Q1	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	215500000	USD
CY2013Q1	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	577500000	USD
CY2013Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	350000000	USD
CY2013Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	399400000	USD
CY2013Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1848000000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	16030100000	USD
CY2013Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14030000000	USD
CY2013Q1	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	27000000	USD
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1665300000	USD
CY2013Q1	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1355400000	USD
CY2013Q1	us-gaap	Other Short Term Investments OtherShortTermInvestments	17000000	USD
CY2013Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	172900000	USD
CY2013Q1	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	4098900000	USD
CY2013Q1	us-gaap	Other Receivables OtherReceivables	928200000	USD
CY2013Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2013Q1	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	577500000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	135400000	USD
CY2013Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1891000000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	28660700000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	468600000	USD
CY2013Q1	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	30200000	USD
CY2013Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	1482400000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1738100000	USD
CY2013Q1	us-gaap	Goodwill Goodwill	17489500000	USD
CY2013Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9055800000	USD
CY2013Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	6215400000	USD
CY2013Q1	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	57300000	USD
CY2013Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2359700000	USD
CY2013Q1	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	8632400000	USD
CY2013Q1	us-gaap	Unearned Premiums UnearnedPremiums	865700000	USD
CY2013Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2936800000	USD
CY2012Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	162200000	USD
CY2013Q1	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	770800000	USD
CY2013Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3287900000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	971800000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	35090600000	USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	3000000	USD
CY2013Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10697400000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13275100000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	342500000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	24318000000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59408600000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2484600000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	16912900000	USD
CY2012Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1212400000	USD
CY2012Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	14800000	USD
CY2012Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3687400000	USD
CY2012Q4	us-gaap	Other Receivables OtherReceivables	928800000	USD
CY2012Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	228500000	USD
CY2012Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	564600000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	243200000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1829000000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	28268400000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	431500000	USD
CY2012Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	30100000	USD
CY2012Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	1387700000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1738300000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	17510500000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9102800000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	486100000	USD
CY2012Q4	us-gaap	Assets Assets	58955400000	USD
CY2012Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	6174500000	USD
CY2012Q4	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	61300000	USD
CY2012Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2345700000	USD
CY2012Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	8581500000	USD
CY2012Q4	us-gaap	Unearned Premiums UnearnedPremiums	896800000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3132500000	USD
CY2012Q4	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	69300000	USD
CY2012Q4	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	564700000	USD
CY2012Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	250000000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	557100000	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1785000000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15836900000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14170800000	USD
CY2012Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	750800000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3381000000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1013200000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	35152700000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	3000000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10853500000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12647100000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	299100000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	23802700000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58955400000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	17006700000	USD
CY2013Q1	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	904000000	USD
CY2013Q1	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	464400000	USD
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	300693279	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	300693279	shares
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	16033100000	USD
CY2012Q4	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	869900000	USD
CY2012Q4	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	426000000	USD
CY2012Q4	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	27100000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	304715144	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	304715144	shares
CY2013Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	204800000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2013Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	16435600000	USD
CY2013Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	990100000	USD
CY2013Q1	us-gaap	Other Income OtherIncome	120600000	USD
CY2013Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	17546300000	USD
CY2013Q1	us-gaap	Net Investment Income NetInvestmentIncome	162000000	USD
CY2013Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	16800000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	37900000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	37900000	USD
CY2013Q1	us-gaap	Revenues Revenues	17687200000	USD
CY2012Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	14138500000	USD
CY2012Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	995800000	USD
CY2012Q1	us-gaap	Other Income OtherIncome	15900000	USD
CY2012Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	15150200000	USD
CY2012Q1	us-gaap	Net Investment Income NetInvestmentIncome	169000000	USD
CY2012Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	106900000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	13700000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-2800000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	10900000	USD
CY2012Q1	us-gaap	Revenues Revenues	15415200000	USD
CY2013Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	13748700000	USD
CY2013Q1	us-gaap	Selling Expense SellingExpense	385900000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1979100000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2365000000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	153500000	USD
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	67900000	USD
CY2013Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	16400100000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1287100000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	401900000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	885200000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.92
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.89
CY2013Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.3750
CY2012Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	11771900000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	700000	USD
CY2012Q1	us-gaap	Selling Expense SellingExpense	393300000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1772400000	USD
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2165700000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	109100000	USD
CY2012Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	58700000	USD
CY2012Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	14105400000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1309800000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	453300000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	856500000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.56
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.53
CY2012Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2875
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	65000000	USD
CY2012Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	34500000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-2200000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	107300000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-4800000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	600000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	928600000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	976600000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-6800000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-6700000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-800000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	700000	USD
CY2013Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	8200000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	956900000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	21500000	USD
CY2013Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	186700000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	58600000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	4200000	USD
CY2013Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-700000	USD
CY2013Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	397700000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-224000000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	435600000	USD
CY2013Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	70900000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9100000	USD
CY2013Q1	us-gaap	Depreciation Depreciation	25300000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	10500000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	35100000	USD
CY2013Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-31100000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3955500000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2531800000	USD
CY2013Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	490800000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	109800000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	87400000	USD
CY2013Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	127500000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	7600000	USD
CY2013Q1	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	12900000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107500000	USD
CY2013Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2013Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	340200000	USD
CY2013Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	113400000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23700000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	4200000	USD
CY2013Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	100000000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-579100000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1500000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-819300000	USD
CY2012Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	35700000	USD
CY2013Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2013Q1	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	12800000	USD
CY2013Q1	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	30400000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	10000000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	20100000	USD
CY2012Q1	us-gaap	Depreciation Depreciation	23500000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1195600000	USD
CY2013Q1	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	260300000	USD
CY2013Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	556900000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	19300000	USD
CY2012Q1	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	-156600000	USD
CY2012Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3252400000	USD
CY2012Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	302300000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	74300000	USD
CY2012Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	679800000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	391000000	USD
CY2012Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	100000000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	19300000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	77500000	USD
CY2012Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	59900000	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2731500000	USD
CY2012Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	350800000	USD
CY2012Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	21300000	USD
CY2012Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	100000000	USD
CY2012Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	155200000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-388300000	USD
CY2012Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1300000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	32500000	USD
CY2012Q1	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	23200000	USD
CY2012Q1	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	-156600000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	123800000	USD
CY2012Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	34700000	USD
CY2012Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-79000000	USD
CY2012Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	477600000	USD
CY2012Q1	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	37800000	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	3800000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2900000	USD
CY2012Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	100400000	USD
CY2012Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	95800000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1167000000	USD
CY2012Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-300000	USD
CY2012Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	600000	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	163700000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1223100000	USD
CY2012Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	697600000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2279100000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2201600000	USD
CY2013Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2012Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1200000	USD
CY2013Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	343500000	USD
CY2013Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	48400000	USD
CY2013Q1	us-gaap	Dividends Common Stock DividendsCommonStock	114200000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	23288200000	USD
CY2012Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	679800000	USD
CY2012Q1	us-gaap	Dividends Common Stock DividendsCommonStock	96700000	USD
CY2012Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	40100000	USD
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	23528400000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	43400000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	120100000	USD
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-4000000	USD
CY2013Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">1</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">. Organization</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">References to the terms “we”, “our”, “us”, “WellPoint” or the “Company” used throughout these Notes to Consolidated Financial Statements refer to WellPoint, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">We are </font><font style="font-family:Times New Roman;font-size:10pt;">one of the </font><font style="font-family:Times New Roman;font-size:10pt;">largest</font><font style="font-family:Times New Roman;font-size:10pt;"> health benefits companies</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">in the United</font><font style="font-family:Times New Roman;font-size:10pt;"> States, serving </font><font style="font-family:Times New Roman;font-size:10pt;">35.8</font><font style="font-family:Times New Roman;font-size:10pt;"> medical members through our affiliated health plans and </font><font style="font-family:Times New Roman;font-size:10pt;">approximately</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">68.0</font><font style="font-family:Times New Roman;font-size:10pt;"> individuals through </font><font style="font-family:Times New Roman;font-size:10pt;">all</font><font style="font-family:Times New Roman;font-size:10pt;"> subsidiaries as of </font><font style="font-family:Times New Roman;font-size:10pt;">March 31</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">2013</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">We offer a broad spectrum of network-based managed care plans to large and small employer, individual, Medicaid and senior markets. Our managed care plans include: preferred provider organizations, or PPOs; health maintenance organizations, or HMOs; point-of-service, or POS, plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans, or CDHPs; and hospital only and limited benefit products. In addition, we provide a broad array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. We provide an array of specialty and other insurance products and services such as behavioral health benefit services, dental, vision, life and disability insurance benefits, radiology benefit management, analytics-driven personal health care guidance and long-term care insurance. We also provide services to the Federal Government in connection with the Federal Employee Program, or FEP, and various Medicare programs. Finally, we sell contact lenses, eyeglasses and other ocular products through our 1-800 CONTACTS, Inc., or 1-800 CONTACTS, business.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">We are an independent licensee of the Blue Cross and Blue Shield Association, or BCBSA, an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California</font><font style="font-family:Times New Roman;font-size:10pt;"> and as</font><font style="font-family:Times New Roman;font-size:10pt;"> the Blue Cross and Blue Shield, or BCBS, licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding </font><font style="font-family:Times New Roman;font-size:10pt;">30</font><font style="font-family:Times New Roman;font-size:10pt;"> counties in the Kansas City area), Nevada, New Hampshire, New York (as the BCBS licensee in </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> New York City metropolitan and surrounding counties and as the Blue Cross or BCBS licensee in </font><font style="font-family:Times New Roman;font-size:10pt;">selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross Blue Shield, or Empire Blue Cross (in our </font><font style="font-family:Times New Roman;font-size:10pt;">New York</font><font style="font-family:Times New Roman;font-size:10pt;"> service areas). </font><font style="font-family:Times New Roman;font-size:10pt;">Through our</font><font style="font-family:Times New Roman;font-size:10pt;"> AMERIGROUP Corporation</font><font style="font-family:Times New Roman;font-size:10pt;"> subsidiary</font><font style="font-family:Times New Roman;font-size:10pt;">, or </font><font style="font-family:Times New Roman;font-size:10pt;">Amerigroup</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">we conduct business in </font><font style="font-family:Times New Roman;font-size:10pt;">Florida, Georgia</font><font style="font-family:Times New Roman;font-size:10pt;">, Kansas, </font><font style="font-family:Times New Roman;font-size:10pt;">Louisiana</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">Maryland,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Nevada,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">New Jersey</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">New Mexico, New York,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Ohio,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Tennessee</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">Texas and Washington</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;"> We also serve customers throughout the country as </font><font style="font-family:Times New Roman;font-size:10pt;">UniCare</font><font style="font-family:Times New Roman;font-size:10pt;">, and in certain </font><font style="font-family:Times New Roman;font-size:10pt;">Arizona</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">California</font><font style="font-family:Times New Roman;font-size:10pt;">, Nevada, New York and Virginia markets through our </font><font style="font-family:Times New Roman;font-size:10pt;">CareMore</font><font style="font-family:Times New Roman;font-size:10pt;"> Health Group, Inc., or </font><font style="font-family:Times New Roman;font-size:10pt;">CareMore</font><font style="font-family:Times New Roman;font-size:10pt;">, subsidiary.</font><font style="font-family:Times New Roman;font-size:10pt;"> We are licensed</font><font style="font-family:Times New Roman;font-size:10pt;"> to conduct insurance operations in all </font><font style="font-family:Times New Roman;font-size:10pt;">50</font><font style="font-family:Times New Roman;font-size:10pt;"> states through our subsidiaries.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p>
CY2013Q1	wlp	Number Of Commercial Medical Members NumberOfCommercialMedicalMembers	35.8	pure
CY2013Q1	wlp	Number Of Individuals Members NumberOfIndividualsMembers	68.0	pure
CY2013Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	pure
CY2013Q1	wlp	Number Of Counties In State Of Kansas Company Does Not Serve NumberOfCountiesInStateOfKansasCompanyDoesNotServe	30	pure
CY2013Q1	wlp	Number Of Counties In New York City Metropolitan Area Company Serves As Independent Licensee NumberOfCountiesInNewYorkCityMetropolitanAreaCompanyServesAsIndependentLicensee	10	pure
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2619200000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	107000000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	90200000	USD
CY2013Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	19673300000	USD
CY2013Q1	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2	-40700000	USD
CY2013Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	18402100000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	17356100000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1324300000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1282100000	USD
CY2013Q1	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	1809	pure
CY2012Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	1709	pure
CY2013Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2687200000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1911200000	USD
CY2013Q1	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	145	pure
CY2012Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	143	pure
CY2013Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	114500000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	158000000	USD
CY2012Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2	-36700000	USD
CY2013Q1	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2	-12400000	USD
CY2012Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2	-14600000	USD
CY2013Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	19673300000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	18586900000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	643000000	USD
CY2013Q1	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	20966100000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	728300000	USD
CY2012Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	19953200000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	155500000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	900000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-1300000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	10000000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-2500000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-10900000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	13100000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	2900000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	161900000	USD
CY2013Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-1400000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	284800000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	14900000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-20200000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	18800000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-1900000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-52200000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	1400000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	105700000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	139900000	USD
CY2013Q1	wlp	Unamortized Debt Discount UnamortizedDebtDiscount	540000000	USD
CY2012Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
CY2012Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-400000	USD
CY2013Q1	wlp	Number Of Assets Measured At Fair Value On Nonrecurring Basis NumberOfAssetsMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2012Q1	wlp	Number Of Assets Measured At Fair Value On Nonrecurring Basis NumberOfAssetsMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2013Q1	wlp	Number Of Liabilities Measured At Fair Value On Nonrecurring Basis NumberOfLiabilitiesMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2012Q1	wlp	Number Of Liabilities Measured At Fair Value On Nonrecurring Basis NumberOfLiabilitiesMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2013Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2012Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2013Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
CY2013Q1	us-gaap	Commercial Paper CommercialPaper	831100000	USD
CY2013Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	13737900000	USD
CY2012Q4	us-gaap	Commercial Paper CommercialPaper	570900000	USD
CY2012Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14407100000	USD
CY2013Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1638800000	USD
CY2012Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1613400000	USD
CY2013Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.312	pure
CY2012Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.346	pure
CY2013Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2013Q1	wlp	Expected Material Contribution ExpectedMaterialContribution	0	USD
CY2012Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2013Q1	wlp	Outstanding Principal Amount Convertible Debt OutstandingPrincipalAmountConvertibleDebt	1500000000	USD
CY2013Q1	wlp	Net Carrying Amount NetCarryingAmount	960000000	USD
CY2013Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	543600000	USD
CY2013Q1	us-gaap	Debt Instrument Convertible Conversion Ratio DebtInstrumentConvertibleConversionRatio	13.2505	pure
CY2013Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	75.4688
CY2013Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2013-02-20
CY2012Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2012-01-24
CY2012Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2012-03-09
CY2013Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2013-03-08
CY2013Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2013-03-25
CY2012Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2012-03-23
CY2013Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	500000	shares
CY2013Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5500000	shares
CY2012Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	10200000	shares
CY2013Q2	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	66.64
CY2013Q1	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	62.41
CY2012Q1	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	66.80
CY2013Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	30900000	USD
CY2013Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	1465700000	USD
CY2013Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	1496600000	USD
CY2012Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	3653900000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17800000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1900000	shares
CY2013Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-600000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-900000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18200000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14900000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	64.67
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	71.00
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	64.83
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	65.27
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	107500000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	96100000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	61.88
CY2013Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	41.15
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y11M
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2100000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-300000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-300000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4100000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	61.81
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	59.01
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	63.06
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2600000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	63.87
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	65.79
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.01250	pure
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.35000	pure
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00600	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.01410	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.34000	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00400	pure
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y0M
CY2012Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.51
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.51
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	-53100000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Gain Loss AvailableForSaleSecuritiesGrossUnrealizedGainLoss	1273500000	USD
CY2013Q1	wlp	Available For Sale Securities Accumulated Other Comprehensive Income Net Deferred Tax Asset AvailableForSaleSecuritiesAccumulatedOtherComprehensiveIncomeNetDeferredTaxAsset	-435500000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	838000000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities	0	USD
CY2013Q1	wlp	Available For Sale Securities Other Than Temporary Impairments In Accumulated Other Comprehensive Income Deferred Tax Liability Asset AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsInAccumulatedOtherComprehensiveIncomeDeferredTaxLiabilityAsset	0	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Debt Securities AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities	0	USD
CY2013Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-53000000	USD
CY2013Q1	wlp	Cash Flow Hedging Instruments Accumulated Other Comprehensive Income Net Deferred Tax Asset CashFlowHedgingInstrumentsAccumulatedOtherComprehensiveIncomeNetDeferredTaxAsset	18600000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	-34400000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax	-674800000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	3700000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	264400000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-406700000	USD
CY2013Q1	wlp	Deferred Net Actuarial Loss Postretirement Benefits DeferredNetActuarialLossPostretirementBenefits	-188300000	USD
CY2013Q1	wlp	Deferred Prior Service Credit Postretirement Benefit Plans DeferredPriorServiceCreditPostretirementBenefitPlans	99800000	USD
CY2013Q1	wlp	Deferred Tax Asset Unrecognized Periodic Benefit Costs Postretirement Benefit Plans DeferredTaxAssetUnrecognizedPeriodicBenefitCostsPostretirementBenefitPlans	34800000	USD
CY2013Q1	wlp	Net Unrecognized Periodic Benefit Costs Postretirement Benefit Plans NetUnrecognizedPeriodicBenefitCostsPostretirementBenefitPlans	-53700000	USD
CY2013Q1	wlp	Accumulated Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax AccumulatedOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-1100000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	400000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-700000	USD
CY2012Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	-79500000	USD
CY2012Q1	us-gaap	Available For Sale Securities Gross Unrealized Gain Loss AvailableForSaleSecuritiesGrossUnrealizedGainLoss	1110800000	USD
CY2012Q1	wlp	Available For Sale Securities Accumulated Other Comprehensive Income Net Deferred Tax Asset AvailableForSaleSecuritiesAccumulatedOtherComprehensiveIncomeNetDeferredTaxAsset	-389900000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	720900000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities	-2800000	USD
CY2012Q1	wlp	Available For Sale Securities Other Than Temporary Impairments In Accumulated Other Comprehensive Income Deferred Tax Liability Asset AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsInAccumulatedOtherComprehensiveIncomeDeferredTaxLiabilityAsset	1000000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Debt Securities AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities	-1800000	USD
CY2012Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-53400000	USD
CY2012Q1	wlp	Cash Flow Hedging Instruments Accumulated Other Comprehensive Income Net Deferred Tax Asset CashFlowHedgingInstrumentsAccumulatedOtherComprehensiveIncomeNetDeferredTaxAsset	18700000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	-34700000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax	-642400000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	4500000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	258300000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-379600000	USD
CY2012Q1	wlp	Deferred Net Actuarial Loss Postretirement Benefits DeferredNetActuarialLossPostretirementBenefits	-230800000	USD
CY2012Q1	wlp	Deferred Prior Service Credit Postretirement Benefit Plans DeferredPriorServiceCreditPostretirementBenefitPlans	112900000	USD
CY2012Q1	wlp	Deferred Tax Asset Unrecognized Periodic Benefit Costs Postretirement Benefit Plans DeferredTaxAssetUnrecognizedPeriodicBenefitCostsPostretirementBenefitPlans	47800000	USD
CY2012Q1	wlp	Net Unrecognized Periodic Benefit Costs Postretirement Benefit Plans NetUnrecognizedPeriodicBenefitCostsPostretirementBenefitPlans	-70100000	USD
CY2012Q1	wlp	Accumulated Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax AccumulatedOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	500000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	-200000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	300000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	235000000	USD
CY2013Q1	wlp	Total Securities Gross Unrealized Gain TotalSecuritiesGrossUnrealizedGain	1326600000	USD
CY2012Q1	wlp	Total Securities Gross Unrealized Gain TotalSecuritiesGrossUnrealizedGain	1190300000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	4800000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	62400000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	6800000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-800000	USD
CY2013Q1	us-gaap	Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss	2400000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax	2600000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Tax Including Portion Attributable To Noncontrolling Interest OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossTaxIncludingPortionAttributableToNoncontrollingInterest	1200000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	400000	USD
CY2013Q1	wlp	Other Net Change In Unrecognized Periodic Benefit Costs For Defined Benefit Pension And Postretirement Benefit Plans Tax Benefit Expense OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense	4400000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-500000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	10500000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	6700000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	700000	USD
CY2012Q1	us-gaap	Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss	24400000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax	33600000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Tax Including Portion Attributable To Noncontrolling Interest OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossTaxIncludingPortionAttributableToNoncontrollingInterest	2600000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	400000	USD
CY2012Q1	wlp	Other Net Change In Unrecognized Periodic Benefit Costs For Defined Benefit Pension And Postretirement Benefit Plans Tax Benefit Expense OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense	4500000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	400000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	65900000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	29700000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	44900000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	43400000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	120100000	USD
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	303200000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335000000	shares
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2700000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	305900000	shares
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4000000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	339000000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11500000	shares
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10100000	shares
CY2013Q1	wlp	Potentially Dilutive Restricted Stock Units Contingent On Operating Results PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults	900000	shares
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1212600000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1367600000	USD

Files In Submission

Name	View Source	Status
0001193125-13-170158-index-headers.html	Edgar Link	pending
0001193125-13-170158-index.html	Edgar Link	pending
0001193125-13-170158.txt	Edgar Link	pending
0001193125-13-170158-xbrl.zip	Edgar Link	pending
d522011d10q.htm	Edgar Link	pending
d522011dex102s.htm	Edgar Link	pending
d522011dex103.htm	Edgar Link	pending
d522011dex10t.htm	Edgar Link	pending
d522011dex10u.htm	Edgar Link	pending
d522011dex311.htm	Edgar Link	pending
d522011dex312.htm	Edgar Link	pending
d522011dex321.htm	Edgar Link	pending
d522011dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wlp-20130331.xml	Edgar Link	completed
wlp-20130331.xsd	Edgar Link	pending
wlp-20130331_cal.xml	Edgar Link	unprocessable
wlp-20130331_def.xml	Edgar Link	unprocessable
wlp-20130331_lab.xml	Edgar Link	unprocessable
wlp-20130331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELV
Elevance Health, Inc. Stock $elv

2013 Q1 Form 10-Q Financial Statement

#000119312513170158 Filed on April 24, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV Elevance Health, Inc. Stock $elv

2013 Q1 Form 10-Q Financial Statement

#000119312513170158 Filed on April 24, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV
Elevance Health, Inc. Stock $elv